Spotlight: NIST Researchers Analyze the Novavax Vaccine From Multiple Angles
Source:
nistNeutronResearch
August 29, 2022 · 05:00
From the publisher
A team of three NIST researchers, each with unique expertise, is studying a vaccine developed by biotech company Novavax for SARS-CoV-2, the virus that causes COVID-19.
Spotlight: NIST Researcher Studies How Communities Can ‘Bounce Back’ After a Disaster
nistResilience
Oct 25, 2024 · 05:00
Spotlight: NIST Researcher Julie Rieland Works Toward Recycling and Reusing Synthetic Plastics Used in Agriculture
nistChemistry
Jun 18, 2024 · 05:00
Spotlight: NIST Researchers Are Helping Make Communities More Resilient Through Wind Tunnel Testing of Building Models
nistBuildingsConstruction
Jun 11, 2024 · 05:00
The original article opens on the publisher's website.
More from General
View topic →Situational Awareness builds relationships with new brokers as it attempts rebound
financialTimes
Sep 11, 2026 · 10:15
The legal drama of imprisoned Sam Bankman-Fried is waiting on its last act
coinDesk
Sep 11, 2026 · 10:12
Election officials ban certain public workers from trading on prediction markets ahead of midterms
cnbc
Sep 11, 2026 · 10:00
Is Bessent winning the wrong battle in markets?
financialTimes
Sep 11, 2026 · 10:00
In pictures: The U.S. commemorates the 25th anniversary of 9/11
cnbc
Sep 11, 2026 · 09:50